Congenital Transmission of Lineages I and II of Trypanosoma Cruzi
Sponsor: Institute for Clinical Effectiveness and Health Policy
A observational or N/A phase clinical study on Chagas Disease, this trial is completed. The trial is conducted by Institute for Clinical Effectiveness and Health Policy and has accumulated 12 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Jan 2026 — Present [monthly]
Completed
-
Sep 2025 — Jan 2026 [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
▶ Show 7 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Apr 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institute for Clinical Effectiveness and Health Policy
- Instituto de Enfermedades Infecciosas y Parasitol Antonio Vidal
- Lab de Parasitologia Universidad Autonoma de Yucatan
- Tulane University School of Public Health and Tropical Medicine
- Université Libre de Bruxelles
For direct contact, visit the study record on ClinicalTrials.gov .